Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Moodys
Baxter
AstraZeneca
Medtronic

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Sun Pharm Industries Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for SUN PHARM INDUSTRIES, and when can generic versions of SUN PHARM INDUSTRIES drugs launch?

SUN PHARM INDUSTRIES has one hundred and sixty-seven approved drugs.

There is one US patent protecting SUN PHARM INDUSTRIES drugs.

There are twenty patent family members on SUN PHARM INDUSTRIES drugs in seventeen countries and one hundred and three supplementary protection certificates in fifteen countries.

Summary for Sun Pharm Industries
International Patents:20
US Patents:1
Tradenames:100
Ingredients:97
NDAs:167

Drugs and US Patents for Sun Pharm Industries

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries DOXYCYCLINE HYCLATE doxycycline hyclate TABLET;ORAL 062677-001 Jul 10, 1986 AB RX No No   Start Trial   Start Trial
Sun Pharm Industries ALLOPURINOL allopurinol TABLET;ORAL 071450-002 Jan 9, 1987 AB RX No No   Start Trial   Start Trial
Sun Pharm Industries DEXAMETHASONE dexamethasone TABLET;ORAL 084763-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Sun Pharm Industries TRAMADOL HYDROCHLORIDE tramadol hydrochloride TABLET;ORAL 076100-001 Jun 20, 2002 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Sun Pharm Industries

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Industries BACTRIM sulfamethoxazole; trimethoprim SUSPENSION;ORAL 017560-001 Approved Prior to Jan 1, 1982 RE28636   Start Trial
Sun Pharm Industries BACTRIM PEDIATRIC sulfamethoxazole; trimethoprim SUSPENSION;ORAL 017560-002 Approved Prior to Jan 1, 1982 RE28636   Start Trial
Sun Pharm Industries BACTRIM DS sulfamethoxazole; trimethoprim TABLET;ORAL 017377-002 Approved Prior to Jan 1, 1982 RE28636   Start Trial
Sun Pharm Industries BACTRIM sulfamethoxazole; trimethoprim TABLET;ORAL 017377-001 Approved Prior to Jan 1, 1982 RE28636   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for Sun Pharm Industries Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1506211 PA2014026,C1506211 Lithuania   Start Trial PRODUCT NAME: DAPAGLIFLOZINUM + METFORMINUM; REGISTRATION NO/DATE: EU/1/13/900 20140116
2582683 2019008 Norway   Start Trial PRODUCT NAME: ALLOPURINOL/LESINURAD ELLER ET FARMASOEYTISK AKSEPTERBART SALT ELLER SALTER DERAV; REG. NO/DATE: EU/1/18/1300/001-004 20180904
1532149 CA 2013 00001 Denmark   Start Trial PRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3,7-DIHYDROPURIN-2,6-DION ENANTIOMERER OG SALTE DERAF - SAERLIGT LINAGLIPTIN - I KOMBINATION MED METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/12/780/001-028 20120720
1412357 77 5006-2008 Slovakia   Start Trial PRODUCT NAME: SITAGLIPTIN A METFORMIN; NAT. REG.NO/DATE: EU/1/08/455/001-014, EU/1/08/456/001-014, EU/1/08/457/001-014 20080716; FIRST REG.:CH 58450 01-03 20080408
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Moodys
Colorcon
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.